Injectsense, Inc.
Injectsense enables tracking of progressive disease indicators and improved therapy management by providing continuous, clinically actionable information through an injectable ultra-miniature sensor coupled with a secure digital health platform. Our sensor, which can be delivered during a doctor`s office visit, transforms the care model by enabling medical teams to track the disease at the pace of its evolution, whether months or years, receive early warning signs and provide preventive therapy. The configurable-on-demand sensor monitors patients 24/7, requires no patient lifestyle changes and reduces the need for medical office visits. More significantly, it allows physicians to establish an individual patient baseline for comparison, to receive data quickly at any time of day, to see histories and hourly dynamic disease state before irreversible damage is done, and to increase the effectiveness of drug therapy by tracking the effects of pharmaceuticals on key indicators over time.
Company details
Find locations served, office locations
- Business Type:
- Technology
- Industry Type:
- Clinical Services
- Market Focus:
- Internationally (various countries)
Injectsense: Improved Care Through Continuous Information
A Serious Unmet Need -- with Significant Quality-of-Life Implications
We live in a new era where we are constantly connected. We receive remote updates on almost all information critical to our lives and lifestyle, and we have the ability to monitor event status and to predict and plan for change. Yet in the medical field, a physician treating a progressive disease often has no choice but to be reactive -- often with harmful results. Critical data on patient disease state is collected infrequently during sporadic office visits, yielding only a single data point to interpret past trends and assess long-term risk. Unlike our personal updates, continuously available via sensors, GIS, and smart phone connectivity, there is no continuous stream of physiological measurement data from patients that can allow physicians to track and anticipate changes in disease status. The medical team cannot see how patient activity may be affecting disease indicators, and they can't see whether patients are even complying with drug therapy. The end result? More patient visits to the ER and doctor's office -- often when physiological damage has already been done.
A Digital Health Platform for Effective Therapy Management
The InjectSense digital health platform streamlines data into dependable information that helps physicians and clinical teams focus their attention on the right problem. Data-based guidance alerts -- coming directly from our injected sensors -- shows them how and whether they are affecting disease indicators and provides them with a tool to accurately determine and verify treatment with repeatable, predictable results. The system provides a way for physicians faced with an overload of data and many patient variables to better manage their practice by supplementing the patient-practitioner relationship. It provides a critical link from patient to physician, allows clinicians to track the patient outside office hours, determine priority cases, and customize treatment.
Benefits for Pharmaceutical Companies: Visibility Into Drug Effectiveness
For pharmaceutical manufacturers the Injectsense platform data streams offer an unprecendented high-value window into drug effectiveness. Injectsense will make available anonymized and encrypted raw patient data that will enable researchers to see individual physiological baselines of the monitored parameter as well as effects on those baselines from drugs under controlled timing scenarios. In this way pharmaceutical firms can document drug correlations, trends, and even the interference of one drug with another on the measured variable. These observations will allow them to enhance formulas and even determine drug delivery timing improvements.